Stock Taper
SCREENER COMPARE ANY 2 STOCKS
ZYBT
ZHENGYE BIOTECHNOLOGY HOLDING LIMITED
NASDAQ
$1.73
▼ DOWN 1.70% (-0.03)

KEY STATISTICS

Market Cap$81.99 M
52w High$13.08
52w Low$0.62
Dividend Yield—
Frequency—
P/E-7.86
Volume36.92K
Shares Out.47.39M

COMPANY

LEADERSHIP

Songlin Song
CHIEF EXECUTIVE
Songlin Song

ABOUT

SECTOR
Healthcare
WENT PUBLIC
January 7, 2025
METHOD OF GOING PUBLIC
N/A
FULL TIME EMPLOYEES
269

PRICE

$1.73 ▼ DOWN 1.70% (−$0.03)
$1.68$1.72$1.76$1.809:33 AM10:37 AM11:42 AM12:46 PM1:50 PM2:55 PM3:59 PM1.73

About Zhengye Biotechnology Holding Limited

https://www.jlzybio.com ↗

Zhengye Biotechnology Holding Limited, founded in 2004 in Jilin, China, develops and sells veterinary vaccines for livestock and pets, exporting to Vietnam, Pakistan, and Egypt, and is a subsidiary of Securingium Holding Limited.

INDUSTRY

Drug Manufacturers - Specialty & Generic

A PRODUCT ZHENGYE BIOTECHNOLOGY HOLDING LIMITED IS KNOWN FOR

Zhengyuanzhen (PCV2 Subunit Vaccine)
Zhengyuanzhen (PCV2 Subunit Vaccine)

Zhengyuanzhen is a flagship subunit vaccine by Zhengye Biotechnology that prevents Porcine Circovirus Type 2 (PCV2), recognized as "Excellent Vaccine Product of the Year" at the 2025 China Swine Industry Glory List.

COMPETITORS

COMPETITOR
ELAN COMPARE
MRK COMPARE
PAHC COMPARE
ZTS COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
1
LISTED HERE
1
RANKED BY POSITION SIZE
PGJ
0.02% · 32.6K

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity2
Price To Earnings1
Price To Book3
Overall Score2

INSIDER TRADES

★
DIRECTOR, 10 PERCENT OWNER:
Han Zhenfa
— · —
2026-06-25
★
OFFICER
Cheng Yuhong (nmn)
— · —
2026-06-25
★
OFFICER
Song Songlin
— · —
2026-06-25
★
OFFICER
Wang Ping (nmn)
— · —
2026-06-25

SECTORS PEERS

PEERPRICE
CRDL$1.94COMPARE
PDEX$62.55COMPARE
SRZN$22.42COMPARE
APYX$3.08COMPARE
ONCY$0.86COMPARE
SERA$2.07COMPARE
EXOZ$7.17COMPARE
TIL$7.58COMPARE